News Image

Friday's session: top gainers and losers

By Mill Chart

Last update: Sep 30, 2022

Let's have a look at what is happening on the US markets in the middle of the day on Friday. Below you can find the top gainers and losers in today's session.

Gainers

TickerChangeComment
ATXI54.28%AVENUE THERAPEUTICS INC's (NASDAQ:ATXI) shares rose 54.28% to $11.19 during Friday's session. The stock is trading 101.0% higher than a month ago.
SOBR39.89%SOBR SAFE INC's (NASDAQ:SOBR) stock price increased by 39.89% to $2.7. Yesterday the company had a press release: SOBR Safe Technology Is Doing More Than Generating Revenues And Creating Shareholder Value; It’s Saving Lives ($SOBR).
FNGR38.92%FINGERMOTION INC's (NASDAQ:FNGR) stock price increased by 38.92% to $2.57. In the last month the share price increased with 98.92%.
FXLV34.71%F45 TRAINING HOLDINGS INC's (NYSE:FXLV) stock price is advancing with 34.71% to a price of $2.95. Shareholders saw the stock price going 44.56% lower in the past 3 months.
INM33.97%INMED PHARMACEUTICALS INC's (NASDAQ:INM) stock price increased by 33.97% to $7.69. In the last 3 months the share price dropped with 51.15%.
IGMS24.94%IGM BIOSCIENCES INC's (NASDAQ:IGMS) shares rose 24.94% to $24.27 during Friday's session. Shareholders saw the stock price going 70.52% lower is the past year.
AEI21.86%ALSET EHOME INTERNATIONAL IN's (NASDAQ:AEI) stock price is advancing with 21.86% to a price of $0.24. Shareholders saw the stock price going 27.48% lower in the past month.
REE19.05%REE AUTOMOTIVE LTD - CLASS A's (NASDAQ:REE) stock price increased by 19.05% to $0.74. The stock is trading 45.32% lower than a month ago.
CTV19.01%INNOVID CORP's (NYSE:CTV) shares rose 19.01% to $2.88. Shareholders saw the stock price going 34.06% lower in the past month.
LITM18.91%SNOW LAKE RESOURCES LTD's (NASDAQ:LITM) stock price is advancing with 18.91% to a price of $1.85. In the last month the share price dropped with 33.05%.

Our top gainers screener will show you the full list.

Losers

TickerChangeComment
AVCTW-39.52%PENSARE ACQUISITION CORP-CW's (NASDAQ:AVCTW) shares fell 39.52% to $0.04. In the last 3 months the stock gained 79.57%.
AVCT-37.97%AMERICAN VIRTUAL CLOUD TECHN's (NASDAQ:AVCT) stock price decreased by 37.97% to $0.19. A press release (AVCT Announces Intent to Effect Reverse Stock Split) was released yesterday.
AEHL-32.62%ANTELOPE ENTERPRISE HOLDINGS's (NASDAQ:AEHL) stock price is declining with 32.62% to a price of $0.62. In the last 6 months the share price dropped with 31.34%.
ATER-28.93%ATERIAN INC's (NASDAQ:ATER) shares fell 28.93% to $1.4. In the last year the stock lost 81.22%.
FEAM-24.27%5E ADVANCED MATERIALS INC's (NASDAQ:FEAM) shares fell 24.27% to $10.63. A press release (5E Advanced Materials Reports Full Year 2022 Results) was released two days ago.
RCII-20.69%RENT-A-CENTER INC's (NASDAQ:RCII) stock price decreased by 20.69% to $17.71. Yesterday the company had a press release: Rent-A-Center, Inc. Announces New EVP – Chief Financial Officer and Updates Third Quarter 2022 Guidance.
CMRAW-20.29%COMERA LIFE SCIENCES -CW27's (NASDAQ:CMRAW) shares fell 20.29% to $0.06 during Friday's session. In the last 3 months the share price dropped with 44.8%.
OPGN-20.24%OPGEN INC's (NASDAQ:OPGN) stock price decreased by 20.24% to $0.3. A press release (OpGen Announces $3.38 Million Registered Direct Offering) was released earlier today.
CCL-20.2%CARNIVAL CORP's (NYSE:CCL) shares fell 20.2% to $7.31 during Friday's session. Shareholders saw the stock price going 54.31% lower is the past 6 months.
CUK-19.71%CARNIVAL PLC-ADR's (NYSE:CUK) shares fell 19.71% to $6.46 during Friday's session. The company's earnings where released Yesterday. Shareholders saw the stock price going 55.95% lower is the past 6 months.

For the full top loser list go to our top losers screener.

Back

AVENUE THERAPEUTICS INC

NASDAQ:ATXI (4/23/2024, 7:00:00 PM)

After market: 0.1329 0 (-0.82%)

0.134

+0 (+3%)

ATXI News

News Image14 days ago - ChartmillTop movers in Tuesday's after hours session

Get insights into the top gainers and losers of Tuesday's after-hours session.

News Imagea month ago - Avenue TherapeuticsAvenue Therapeutics to Host Virtual Key Opinion Leader (KOL) Event on April 4, 2024

MIAMI, March 25, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company...

News Imagea month ago - BusinessInsiderATXI Stock Earnings: Avenue Therapeutics Beats EPS for Q4 2023

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Avenue Therapeutics (NASDAQ:ATXI) just reported results for the fourth quarter ...

News Imagea month ago - InvestorPlaceATXI Stock Earnings: Avenue Therapeutics Beats EPS for Q4 2023

ATXI stock results show that Avenue Therapeutics beat analyst estimates for earnings per share the fourth quarter of 2023.

News Imagea month ago - Avenue TherapeuticsAvenue Therapeutics Reports Full Year 2023 Financial Results and Recent Corporate Highlights

- Enrollment completed in Phase 1b/2a clinical trial of AJ201 for spinal and bulbar muscular atrophy; topline data expected in second quarter of 2024 - ...

News Imagea month ago - Avenue TherapeuticsAvenue Therapeutics Receives Positive Listing Determination from Nasdaq

MIAMI, March 15, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company...

News Imagea month ago - Avenue TherapeuticsAvenue Therapeutics to Present BAER-101 Preclinical Data at American Society for Experimental Neurotherapeutics (ASENT) 2024 Annual Meeting

BAER-101 demonstrated full suppression of seizure activity in SynapCell's GAERS model of absence epilepsy, a proven indicator of efficacy in anti-seizure...

News Image2 months ago - Avenue TherapeuticsAvenue Therapeutics Announces Publication in Drug Development Research Highlighting First-In-Class Preclinical Data of BAER-101 in a Translational Model of Absence Epilepsy

-In vivo data supports BAER-101’s unique ability to significantly suppress seizures using the SynapCell's Genetic Absence Epilepsy Rat from Strasbourg...

News Image3 months ago - Avenue TherapeuticsAvenue Therapeutics to Present at Sidoti January Micro-Cap Investor Conference

MIAMI, Jan. 11, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company focused...

News Image4 months ago - Avenue TherapeuticsAvenue Therapeutics Enters into Warrant Exercise Transactions for $5.0 Million in Proceeds

MIAMI, Jan. 05, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company focused...

ATXI Links
Follow us for more